SSAA09E2

CAS No. 883944-52-3

SSAA09E2( —— )

Catalog No. M24901 CAS No. 883944-52-3

SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 69 In Stock
5MG 110 In Stock
10MG 177 In Stock
25MG 410 In Stock
50MG 605 In Stock
100MG 860 In Stock
500MG 1728 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SSAA09E2
  • Note
    Research use only, not for human use.
  • Brief Description
    SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
  • Description
    SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    Human ACE2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    883944-52-3
  • Formula Weight
    300.36
  • Molecular Formula
    C16H20N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:230 mg/mL?(765.75 mM;?Need ultrasonic)
  • SMILES
    O=C(C1=CC=NO1)NCC2=CC=C(N3CCN(C)CC3)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.?Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496.
molnova catalog
related products
  • Voglibose

    Voglibose, an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.

  • ME-3221

    ME-3221 is an angiotensin AT1 receptor antagonist that prevents hypertensive complications in aged stroke-prone hypertensive rats.

  • Fosinopril sodium

    Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor.